Latest news

• National trial to rapidly find treatments for severe flu this winter launched in UK

  The £2.9m trial will work with the National Institute for Health and Care Research (NIHR), which is funding the trial, to recruit adults, children and babies over one month old ... Instead, this type of trial keeps research rolling,” explained

• Pandemic Antiviral Discovery initiative created by the Novo Nordisk Foundation, Open Philanthropy and the Gates Foundation

  The initial RFP is scheduled to be announced during the International Conference on Antiviral Research (ICAR) in Seattle, Washington. ... It will also identify new chemical matter – including by compound library screening and structure-guided drug

• Positive COPD data for Synairgen's SNG001 supports COVID-19 programme

  Interim analysis from the phase 2 trial in COPD patients with confirmed respiratory viral infection found that treatment with SNG001 improved lung antiviral responses compared to placebo. ... INF-beta is a naturally occurring protein that controls the

• UK biotech Synairgen reveals promising early results for COVID-19 drug

  INF-beta is a naturally occurring protein that controls the body’s antiviral response, and previous research has found that a lack of INF-beta production in the lungs can be ... Trust and the highly expert research teams across the NIHR network and

• Daily Brief: DeepMind and NHS success in AI, Bayer invests in COPD, Alecensa OK in Scotland

  We’ll continue to keep you updated as we make progress.”. Bayer buys into antiviral research for lung disease. ... The goal of the new Haplogen-Bayer research alliance is to develop new antiviral compounds addressing the high unmet medical need in